A Randomized cross-over clinical trial to assess the effectiveness of oral contraceptives including Contrasmine, Etisterone and Desoceptive with Ovustop-L (LD) on clinical, biochemical and metabolic findings, and quality of life in women with polycystic ovary syndrome.

Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, I0 个研究点目标入组 200 人开始时间: 待定最近更新: 2018年2月22日

试验速览

暂无简介。

•inclusion criteria: Existent of diagnostic criteria for polycystic ovary syndrome based on Androgen Excess and PCOS Society (AES), Lack of pregnancy diagnosis and tendency to it for a year or more, lack of using hormonal, anti-androgens or sensitizers drugs at least 3 months before the study, Failure to detect other causes of hyperandrogenism, Not having chronic medical conditions, high and severe blood pressure, recent surgery or known cancer, 6- Not smoking and non-obesity.
•Exclusion criteria: Not adherence to prescribed medications for more than two months, detection of chronic medical disorders, Appearing the serious effects such as thrombosis contraceptive.

发起方

Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, I